HealthcareServices

Chronic Venous Occlusions Treatment Market 2026–2030: Emerging Trends and Forecast Opportunities

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the chronic venous occlusions treatment market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Chronic Venous Occlusions Treatment Market?

The market size for chronic venous occlusions treatment has demonstrated substantial growth in recent years. This market is set to expand from $7.15 billion in 2025 to $7.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.3%. The historical period’s growth can be linked to the increasing prevalence of venous disorders, wider availability of endovascular treatment options, growth in hospital-based interventional procedures, rising awareness of chronic venous diseases, and expanded use of anticoagulant therapies.

The chronic venous occlusions treatment market size is anticipated to undergo significant expansion in the upcoming years. It is projected to ascend to $10.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This expansion during the forecast period is primarily fueled by an expanding aging demographic, the escalating demand for outpatient venous procedures, a heightened emphasis on early disease detection, the proliferation of advanced imaging-assisted treatments, and the increasing uptake of next-generation venous devices. Prominent trends expected over this period include the wider adoption of minimally invasive venous interventions, the growing application of advanced venous stenting technologies, an evolving preference for combination device and drug therapies, the broadening scope of image-guided endovascular procedures, and an intensified focus on long-term occlusion management strategies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13286&type=smp

Which Drivers Are Supporting The Rise Of The Chronic Venous Occlusions Treatment Market?

The increasing incidence of obesity is projected to boost the growth of the chronic venous occlusion treatment market moving forward. Obesity is a medical condition defined by an excessive accumulation of body fat, generally resulting in an individual possessing a body mass index (BMI) of 30 or higher. Chronic venous occlusion treatment plays a role in managing obesity-associated symptoms such as edema and skin changes through improved blood flow and reduced inflammation, thereby contributing to enhanced obesity management. As an illustration, in March 2023, the World Heart Federation, a Switzerland-based non-government global cardiovascular community, reported that approximately 2.3 billion adults and children worldwide were obese or overweight. Furthermore, with the current trajectory, the number of people affected by obesity is anticipated to reach 2.7 billion by 2025. Hence, the rising prevalence of obesity is a primary driver for the expansion of the chronic venous occlusion treatment market.

What Segments Are Identified Within The Structure Of The Chronic Venous Occlusions Treatment Market?

The chronic venous occlusions treatment market covered in this report is segmented –

1) By Product: Devices, Drugs

2) By Application: Varicose Veins, Venous Stasis Ulcers, Edema, Deep Vein Thrombosis, Other Applications

3) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Trauma centers, Other End-Users

Subsegments:

1) By Devices: Venous Stents, Catheters, Endovenous Laser Therapy (EVLT) Devices, Angioplasty Balloons

2) By Drugs: Anticoagulants, Thrombolytics, Anti-inflammatory Medications, Pain Management Drugs

How Are Emerging Trends Affecting The Progression Of The Chronic Venous Occlusions Treatment Market?

Leading companies in the chronic venous occlusion treatment market are concentrating on developing novel solutions, including implantable medical devices specifically for managing symptomatic venous outflow obstruction in patients suffering from chronic venous insufficiency (CVI). An implantable medical device refers to a surgically inserted device intended to remain within the body for an extended duration, frequently used for diagnosing, treating, or monitoring various medical conditions. For instance, in June 2024, Koninklijke Philips N.V. (Philips), a technology company based in the Netherlands, unveiled the Duo Venous Stent System, which is an implantable medical device. This Duo Venous Stent System by Koninklijke Philips N.V. features a dual-layer construction that enhances its flexibility and radial strength, providing superior vein support. Its advanced coating further improves biocompatibility and minimizes the risk of thrombosis, while a precise delivery system ensures accurate placement even in challenging anatomical situations.

Which Leading Companies Dominate The Chronic Venous Occlusions Treatment Market Share?

Major companies operating in the chronic venous occlusions treatment market are Cardinal Health Inc., Bayer AG, Sanofi S.A., 3M Company, Bristol-Myers Squibb Company, Medtronic PLC, Becton, Dickinson and Company (BD), Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Ethicon Inc., Philips Medical Systems, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Integer Holdings Corporation, Penumbra Inc., Inari Medical, Argon Medical Devices Inc., AngioDynamics Inc., Rontis Corporation, Endologix, Richard Wolf GmbH, SIGVARIS AG, enVVeno Medical Corporation, LimFlow SA

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/chronic-venous-occlusions-treatment-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Chronic Venous Occlusions Treatment Market?

North America was the largest region in the chronic venous occlusions treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic venous occlusions treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Chronic Venous Occlusions Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13286&type=smp

Browse Through More Reports Similar to the Global Chronic Venous Occlusions Treatment Market 2026, By The Business Research Company

Bleeding Disorders Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

Retinal Vein Occlusion Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-vein-occlusion-treatment-global-market-report

Retinal Vein Occlusion Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-vein-occlusion-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795